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Abstract
Background: Peripheral arterial disease (PAD), a slowly progressive atherosclerotic disease affecting vital organs of
the body, is increasingly recognized as a health burden worldwide. Epidemiological information on peripheral
arterial disease is scarce in Sri Lanka. The present study intended to estimate the prevalence and associated factors
of PAD among adults aged 40–74 years in Gampaha district, Sri Lanka.
Methods: A cross-sectional study was carried out to estimate the prevalence of PAD among adults aged 40–74
years in four randomly selected divisional secretariat areas in Gampaha district in 2012–2013. The sample size of
2912 adults was obtained from 104 clusters using multistage probability proportionate to size sampling. The
number of individuals to be included in the 5-year age groups between 40 and 74 years was determined based on
the population proportion of the respective age groups in the district. Cluster size was 28, and equal numbers of
males and females were selected for each age group per cluster. PAD was defined as having an ankle-brachial
pressure index ≤ 0.89.
Results: The age-and sex-standardized prevalence of PAD, adjusted for the sensitivity of the ankle-brachial pressure
index was 3.6 % (95 % CI 2.9–4.3 %), and no significant difference was found between males (3.7 %) and females
(3.6 %) (p = 0.08). Eighty-eight individuals were newly identified as having PAD, and a significant trend of prevalence
with increasing age was observed (p < 0.001). Histories of diabetes mellitus, hypertension, dyslipidemia, coronary
artery disease, cerebrovascular accident, smoking, and erectile dysfunction among males were significantly
associated with PAD (p <0.001). Only one third of those with PAD experienced claudication symptoms.
Conclusions: PAD was found to be a hidden disease in the Gampaha district population. Although there is
minimal attention on PAD at present, the disease is likely to become a problematic public health concern in Sri
Lanka, particularly with its aging population. Primary prevention measures to modify risk factors of PAD, including
screening activities for early identification, should be a priority.
Background
Peripheral Arterial Disease (PAD) is a slowly pro-
gressive atherosclerotic disease usually characterized
by occlusion of lower limb arteries, ultimately caus-
ing acute or chronic limb ischemia [1, 2]. It is the
third most important atherosclerotic disease after
coronary artery disease and cerebrovascular disease
[3] and is increasingly recognized as a health burden
worldwide [1].
The prevalence of PAD in European and Asian popu-
lations is 3–10 % among those aged 40–70 years, and
10–20 % among those over 70 years of age [4–8]. The
ankle-brachial pressure index (ABPI) is a simple, inexpen-
sive, and noninvasive test that provides objective measure-
ments. It can be easily performed in field epidemiological
surveys, in clinical practice, and in vascular laboratories
to diagnose PAD. The ABPI is defined as the ratio of
the highest ankle systolic blood pressure divided by the
highest brachial systolic blood pressure [9–12].
In Sri Lanka, data on PAD are scarce. Anecdotal evidence
suggests that PAD has been detected in large numbers of
patients in late stages of severe limb ischemia or ischemic
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leg ulceration. PAD has not yet, however, emerged as a
public health problem in Sri Lanka, possibly because of a
lack of data. The present study intended to estimate the
prevalence and associated factors of PAD among adults
aged 40–74 years in Gampaha District, Sri Lanka.
Methods
We employed a cross-sectional study design to estimate
the prevalence of PAD among adults aged 40–74 years
in four randomly selected divisional secretariat areas in
Gampaha District, Sri Lanka in 2012–2013. The district
has been divided into 13 divisional secretariat areas for
administrative convenience. The sample size of 2912
adults, aged 40–74 years, was obtained from 104 clusters
using multistage probability proportionate to size sam-
pling. A cluster was defined as an administrative area of
a village officer and clusters size was 28 (Fig. 1). Admin-
istrative area of a village officer has a population that
Fig. 1 Schematic presentation of the study framework
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ranges from 1000–3000. The proportion of population be-
tween ages 40–74 years is around 27 %. Sample was ob-
tained from each cluster in 5- year age category of 40–44,
45–49, 50–54, 55–59, 60–64, 65–69, 70–74 years and the
number of individuals to be included in different age cat-
egory was determined based on the population proportion
of the respective age categories. Equal number of males
and females were selected for each age category per clus-
ter. The population proportion of 5-year age groups in the
district was obtained from 2001 census data.
The sample size was determine using the formula for
prevalence study described in Lwanga and Lemeshow
[13]. The critical value of specified confidence interval of
95 % is 1.96. Anticipated population prevalence of PAD
was taken as 3.5 % and the absolute precision required
on either side of the proportion (1.0 %). Since cluster
sampling method was adopted the effect of clustering
was overcome by making a correction for design effect.
The design effect was taken as 2.0. An additional 12 %
was added to account for non response among partici-
pants. Thus, the minimum sample size required to de-
tect the expected prevalence of PAD in the community
with 95 % confidence interval and with 1 % precision
was 2912.
A prevalidated, interviewer-administered question-
naire was used to obtain data. Socio-demographic
characteristics such as age, sex, ethnicity, religion,
level of education, and monthly household income
were obtained. The age was verified by supportive
documents. Medical history and duration of diabetes
mellitus, dyslipidemia, hypertension, coronary arterial
disease (CAD), cerebrovascular disease (CVD), and
PAD was based on self-reporting and was verified ei-
ther by available clinical records or medications.
The assessment of intermittent claudication was based
on the Edinburgh claudication questionnaire [14]. Erect-
ile dysfunction (ED) was defined as the recurrent or per-
sistent inability to attain and/or maintain an erection for
satisfactory sexual performance [15] and the information
on ED was obtained using a selected set of questions.
Lifestyle characteristics of smoking and usage of alco-
hol were also obtained. Smoking exposure was catego-
rized according to the classification of the Centers for
Disease Control and Prevention in the United States
[16]. Lifetime exposure to smoking was assessed by
pack-year smoking values. Pack-years of smoking were
calculated by multiplying the average number of ciga-
rettes smoked per day by the number of years of smok-
ing, then dividing by 20. Alcohol intake was categorized
according to the definition of the National Institute on
Alcohol Abuse and Alcoholism in United States [17].
Body weight was measured in kilogram to the nearest
0.1 kg using a “Seca 876” electronic digital standing-on
weighing scale and the standing body height was
measured in centimeter to the nearest 0.5 cm using a
“Seca 213” stadiometer. Wight and height measurements
were obtained according the guidelines given by An-
thropometry Procedures Manual of Center for Disease
Control and Prevention in the United States [18]. The
categorization of body mass index (BMI) for obesity
was based on the guidelines given by the International
Obesity Task Force-WHO for Asians [19]. Each lower
limb of the participants was examined for the status of
pedal pulses; dorsalis pedis, and posterior tibial and
categorized as present, weak or absent pulses. In
addition, lower extremities were examined for signs of
chronic circulatory insufficiency such as absence of hair
growth, skin discoloration, dystrophic toe nails, fissured
skin, ulceration, or gangrene. severity of ischemia of in-
dividuals with PAD was classified according to Fon-
taine’s stages [12].
The measurement of ABPI was performed according
to the procedure described in the American College of
Cardiology and the American Heart Association guide-
lines for the management of patients with peripheral ar-
terial disease [12]. The Summit Vista ABI L450 arterial
Doppler instrument made in United States was used to
assess the ABPI. The ABPI was calculated up to two
decimal places for each lower limb as the ratio of the
highest systolic blood pressures at the ankle to the high-
est of the left and right brachial systolic pressures. The
validity of ABPI to identify PAD was assessed using pa-
tients referred to the vascular laboratory at the National
Hospital Sri Lanka (published separately). Those who
were found with an ABPI of 0.89 or less in either lower
limb were identified as having PAD. For ABPI ≤0.89, the
sensitivity of detecting PAD was 87 %, and specificity
was 99.1 %.
To standardize the performance of ABPI measure-
ments, the principal investigator was a medical doctor
trained under the guidance of a consultant vascular
surgeon in National Hospital Sri Lanka. The Ethics Re-
view Committee of the Faculty of Medicine, University
of Colombo granted the approval for the study. In-
formed consent was obtained from all patients prior to
participation.
Statistical Package for Social Science (SSPS) was used
for analysis. The gross prevalence of PAD was standard-
ized for age and sex using 2011 Sri Lankan census data
and was also adjusted for ABPI score sensitivity. Bivari-
ate analysis, followed by a multiple logistic regression,
was conducted to assess the relationships of demograph-
ics, socioeconomic characteristics, and selected medical
conditions with PAD.
Results
The total number of participants was 2779, with a re-
sponse rate of 95.4 %. The mean age of those with PAD
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was 64.3 years (SD = 7.59); median age was 65 years
(IQR 60–70 years), with a range of 48–74 years.
All those found with PAD in this study (n = 88) were
newly diagnosed with the disease. The crude prevalence
was 3.16 %, and the age- and sex-standardized preva-
lence was 3.13 %. After adjusting for ABPI sensitivity,
the estimated prevalence of PAD among the 40–74 years
age group was 3.6 % (95 % CI2.9–4.3 %). The adjusted
prevalence of PAD for males (3.7 %, 95 % CI2.7–4.7 %)
and females (3.6 %, 95 % CI2.7–4.5 %) was not signifi-
cantly different (p = 0.8). Table 1 shows the age-specific
prevalence of PAD. No cases were found below the age
of 45 years. A statistically significant trend (p < 0.001) of
prevalence with increasing age was additionally discovered.
The demographic and socioeconomic characteristics
of those found with PAD are described in Table 2.
There were no significant differences in the prevalence
of PAD among ethnic groups or between urban and
rural sectors. A significantly higher prevalence of PAD
was found among Christians (5.5 %), those with lower
levels of education (4.6 %), and low-income groups
(4.4 %) (p < 0.01).
Compared to those without PAD, a significantly higher
proportion of those with PAD had histories of diabetes
mellitus (71.6 %), hypertension (78.5 %), dyslipidemia
(73.9 %), CAD (15.9 %), CVD (11.4 %), and ED (62.2 %)
(p < 0.001). Compared with those without PAD, a signifi-
cantly higher proportion of those with PAD had diabetes
mellitus (54.5 %), hypertension (56.7 %), or dyslipidemia
(44.3 %) for 10 years or more (p < 0.01). A significantly
higher proportion of males with PAD was found with
erectile dysfunction (62.2 %) than those without PAD
(p < 0.01). No significant difference was found in BMI
and the usage of alcohol between those with and those
without PAD (p > 0.05). No female smokers took part
in the survey. Among males, there was a significantly
higher proportion of smokers with PAD than without
PAD (p < 0.001).A statistically significant trend in PAD
occurrence was observed with higher exposure to pack-
year smoking (p < 0.001) (Table 3).
There were 130 affected lower limbs among the 88 in-
dividuals identified with PAD. Both pedal pulses were
absent in 63.9 % of lower limbs with PAD. None of those
affected lower limbs had a single normal pedal pulse.
Skin manifestations of chronic circulatory insufficiency
were found only in two third of the affected lower limbs
(Table 4). Majority of those with PAD (62.5 %) belong to
Fontaine’s stage I or asymptomatic and rest of the indi-
viduals (37.5 %) were belong to Fontaine’s stage II. None
of those with PAD found with ischemic rest pain, ulcer-
ation or gangrene (Table 5).
In logistic regression analysis, 5 years or more of dia-
betes mellitus, hypertension or dyslipidemia was signifi-
cantly associated with PAD. The presence of myocardial
infarction, CVA, and exposure to 10 or more pack-years
of smoking were all also significantly associated with
PAD (Table 6).
Discussion
This study was the first community-based prevalence
study on PAD in Sri Lanka and it was carried out in the
Gampaha district. Epidemiological data related to PAD
is scarce in Sri Lanka, and routine health information
systems do not collect morbidity and mortality informa-
tion directly related to PAD. Hence, the findings of this
study will be useful for healthcare providers to estimate
the burden of disease in the country and to plan screen-
ing programs for PAD.
Table 1 Age- and sex-standardized prevalence of peripheral arterial disease by age group (adjusted for the sensitivity of the Ankle
Brachial Pressure Index)
Age group (years) 40–44 45–49 50–54 55–59 60–64 65–69 70–74 Total
Prevalence 0 % 1.2 % 2.3 % 2.6 % 4.9 % 11.2 % 15.6 % 3.6 %







N % N %
Sex
Male 45 3.3 1338 96.7 p = 0.8
Female 43 3.1 1353 96.9
Sector
Rural 65 2.9 2163 97.1 p = 0.1
Urban 23 4.1 528 95.9
Ethnicity p = 0.9
Sinhala 86 3.2 2615 96.8
Others* 02 2.6 76 97.4
Religion p < 0.05
Buddhist 66 2.8 2255 97.2
Christians 22 5.5 378 94.5
Level of education p < 0.01
GCE O/L not completed 39 4.6 853 95.4
GCE O/L completed and above 49 2.7 1838 97.3
Monthly family income Rs: p < 0.01
<30,000 56 4.4 1227 95.6
≥30,000 - 32 2.1 1464 97.9
*Tamils and Muslims; GCE O/L: General certificate of education ordinary level
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A multistage probability proportionate to size cluster
sampling method was used to obtain a representative
sample from the district. There was high response rate
of 95.4 %. The estimated prevalence of PAD among the
age group of 40–74 years was 3.6 % (95 % CI 2.9–4.3 %).
The age specific prevalence of PAD showed a consistent
increase with advancing age, and there was no signifi-
cant difference in prevalence between males and females.
An urban population study in Chennai, India found a
3.2 % prevalence of PAD in an urban south Indian popula-
tion [5]. The prevalence of PAD reported in a community-
based study among South Asian migrants above the age of
45 years in the UK was 13.2 % (95 % CI 9.7–16.7) [20].
The prevalence of PAD reported in the present study is
lower than that reported in studies from European coun-
tries and from the United States [21–23]. However, there
is consistent evidence to support an age-related increase
in trend [6–8]. Literature reveals no consistent evidence to
Table 3 Selected characteristics among participants by presence of PAD
Characteristics PAD No PAD Significance
(n = 88) (n = 2691)
N % N %
History of diabetes mellitus (yes) 63 71.6 464 17.2 p < 0.01
History of diabetes < 5 years 2 2.3 245 9.1
History of diabetes 5–10 years 13 14.8 129 4.8
History of diabetes 10 years 48 54.5 90 3.3
History of hypertension (yes) 69 78.5 537 19.9 p < 0.01
History of hypertension < 5 years 5 5.7 352 13.1
History of hypertension 5–10 years 15 17.0 120 4.4
History of hypertension 10 years 49 56.7 65 2.4
History of dyslipidemia (yes) 65 73.9 433 16.1 p < 0.01
History of dyslipidemia < 5 years 4 4.5 340 12.6
History of dyslipidemia 5–10 years 22 25.0 65 2.4
History of dyslipidemia 10 years 39 44.3 28 1.1
History of Coronary artery disease (Yes) 14 15.9 85 3.2 p < 0.01
History of Cerebrovascular disease (Yes) 10 11.4 37 1.4 p < 0.01
Presence of Intermittent claudication (Yes) 33 37.5 42 1.5 p < 0.01
Erectile dysfunction among males* (Yes) 28 62.2 281 21.0 p < 0.01
Body mass index kg/m2
<23 43 51.1 1075 38.1 df = 2
23–24.9 18 20.5 567 21.1
≥25 27 28.4 1049 40.8 p > 0.05
Alcohol consumption df = 2
Abstainers 45 51.1 1555 57.8
Less frequent users 29 33.0 639 23.7 p > 0.05
Frequent users 14 15.9 497 18.5
Smoking status PAD (n = 45) No PAD (n = 1338)
Never smoker 06 13.3 645 df = 2 p < 0.001
Current smokers 20 44.4 367
Former smokers 19 42.2 326
Pack year smoking df = 4
Zero (Never smokers) 6 13.3 645
<5 4 8.9 328
5- 4 8.9 174 p < 0.001
10 - 9 20.0 123
≥20 22 48.9 68
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support differences in the prevalence of PAD between the
sexes. Some studies have found a significant difference in
the prevalence between males and females [4, 21], while
others have not [8, 20, 22]. In the present study, all those
found with PAD were newly diagnosed with the disease.
In one Barcelona study, 19 % of those found with PAD
had been diagnosed previously [21]. This finding indicates
the high need for a screening program in Sri Lanka for
early detection and prevention of PAD complications.
The present study found a significantly higher propor-
tion of individuals with diabetes mellitus, hypertension,
and dyslipidemia among those with PAD than among
those without PAD. This tendency has been consistently
supported by other studies [4, 24, 25]. In many studies,
the association of PAD has been assessed only in relation
to the presence or absence-and not the duration—of
these medical conditions. In our study, however, a 5-year
or more duration of diabetes mellitus, dyslipidemia, or
hypertension was found to be significantly associated
with PAD. Although it is difficult to determine the
exact time of onset of these diseases, the known dur-
ation of disease provides important information about
development of PAD. Korhonen [26] reported that
newly diagnosed pre-diabetes or diabetes per se is not
associated with PAD, whereas long-term diabetes re-
mains a well-established risk factor for PAD. A pro-
spective cohort study by Joosten et al. [27] also found
that 5 years or more of diabetes mellitus, dyslipidemia
or hypertension was significantly associated with inci-
dence of PAD.
Significantly higher proportions of vascular co morbid-
ities, such as CAD and CVD, among those with PAD
have been reported in many studies [5, 20, 28]. Com-
pared with their non-PAD counterparts, a significantly
higher proportion of males with PAD were also found to
have ED. Several previous studies also have reported
similar findings [29, 30]. Thus, ED has consequently
become a significant co morbidity and predictor of
asymptomatic PAD among males.
Claudication symptoms were found among only one-
third of those with PAD. Low prevalence of claudication
symptoms has also been reported by many other studies
[8, 31–33]. The usefulness of intermittent claudication
in identifying PAD is therefore limited.
Pedal pulses were categorized as being present, weak,
or absent. Both pedal pulses were absent in almost
two-thirds of PAD lower limbs. Thus, the usefulness of
assessing pedal pulses is much greater than assessing
claudication symptoms in the identification of PAD.
Conclusions
This study revealed that the prevalence of PAD in Sri
Lanka is lower than in Western countries. Significant
associations of PAD were found with aging and other
traditional cardiovascular risk factors. As all individuals
Table 4 Status of pedal pulses and features of chronic circulatory
insufficiency of lower limbs with and without PAD (n = 5558)
Status of pedal pulses PAD No PAD
(n = 130) (n = 5428)
(Dorsalispedis and Posterior tibial pulse) No. % No %
Both pedal pulse absent 83 63.9 – –
Both pedal pulse diminished 25 19.2 93 1.7
One absent pulse with other diminished 22 16.9 114 2.1
One absent pulse and other normal – – 147 2.7
Both pulses normal – – 5074 93.5
Signs of chronic circulatory insufficiencya
No foot signs 42 32.3 4918 90.6
Skin discoloration 58 44.6 258 4.8
Absent hair 44 33.8 89 1.6
Dystrophic nails 34 26.1 112 2.1
Fissured skin 16 12.3 51 0.9
Ulceration or gangrene 00 — 00 –
n number of lower limbs; aOne foot may have more than one sign
Table 5 Severity of the ischemia of those with PAD according
to fontaine’s stages
Grade Symptoms Number Percent
I Asymptomatic 55 62.5
IIa Mild claudication 15 17.0
IIb Moderate – sever claudication 18 20.5
III Ischemic rest pain 00 -
IV Ulceration or gangrene 00 -
Table 6 Results of logistic regression analysis for factors
associated with PAD
Factor Significance
Level of education .610
Monthly family Income .342
Diabetes mellitus less than 5 years .827
Diabetes mellitus 5–9 years .002
Diabetes mellitus 10 years or more .000
Hypertension less than 5 years .246
Hypertension 5–9 years .001
Hypertension 10 years or more .000
Dyslipidemia less than 5 years .080
Dyslipidemia 5–9 years .000
Dyslipidemia 10 years or more .000
Presence of myocardial infarction .043
Presence of cerebrovascular accident .021
Pack years smoking less than 10 .053
Pack year smoking 10 or more .002
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found with PAD in this study were newly identified,
PAD appears to be a hidden disease in the community
and is an emerging public health concern in Sri Lanka,
particularly with the aging population. There is an urgent
need to take primary prevention measures to modify the
risk factors of PAD. Incorporating public awareness activ-
ities about PAD, alongside health education and health
promotion activities related to other non-communicable
diseases, is one vital step towards addressing this need.
Additional priorities beyond public awareness programs
should include screening activities for early PAD identifi-
cation, as well as the strengthening of healthcare facilities
for managing PAD.
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